39
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Relative roles of endothelial cell damage and platelet activation in primary Raynaud's phenomenon (RP) and RP secondary to systemic sclerosis

Pages 290-296 | Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

J. D. Pauling, V. B. O’Donnell & N. J. Mchugh. (2013) The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis. Platelets 24:7, pages 503-515.
Read now
S Ziegler, M Brunner, E Eigenbauer & E Minar. (2003) Long‐term outcome of primary Raynaud's phenomenon and its conversion to connective tissue disease: a 12‐year retrospective patient analysis. Scandinavian Journal of Rheumatology 32:6, pages 343-347.
Read now

Articles from other publishers (30)

Per Vihlborg, Oscar Lundberg, Paul Pettersson-Pablo, Niclas Johansson, Ing-Liss Bryngelsson, Albin Stjernbrandt & Pål Graff. (2024) Blood biomarkers for occupational hand-arm vibration exposure. Toxicology and Industrial Health.
Crossref
Eduardo Delabio Auer, Valéria Bumiller-Bini Hoch, Emiliano Borges da Silva, Yohan Ricci Zonta, Luciane Alarcão Dias-Melicio, Thelma Larocca Skare, Vanessa F. Picceli, Iara José Messias-Reason & Angelica Beate Winter Boldt. (2024) Association of neutrophil extracellular trap levels with Raynaud’s phenomenon, glomerulonephritis and disease index score in SLE patients from Brazil. Immunobiology 229:3, pages 152803.
Crossref
Ariane L. Herrick, Fredrick M. Wigley & Janet Pope. 2024. Raynaud’s Phenomenon. Raynaud’s Phenomenon 343 368 .
Fatemeh Nejatifar, Neda Mirbolouk, Irandokht Shenavar Masooleh, Ehsan Kazemnejad, Banafsheh Ghavidel-Parsa, Amir Mohammad Ghanbari & Habib Zayeni. (2023) Association between neutrophil/lymphocyte ratio and disease severity in scleroderma patients. Heliyon 9:10, pages e20576.
Crossref
Iqra Nawaz, Yashfa Nawaz, Eisha Nawaz, Muhammad Romail Manan & Adil Mahmood. (2022) Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies. Cureus.
Crossref
Cintia Zumstein Camargo & Cristiane Kayser. (2019) Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study. International Journal of Rheumatic Diseases 22:7, pages 1319-1326.
Crossref
Amaal Eman Abdulle, Anniek M. van Roon, Andries J. Smit, Andreas Pasch, Matijs Meurs, Hendrika Bootsma, Stephan J. L. Bakker, Mohammad Y. Said, Bernadette O. Fernandez, Martin Feelisch, Harry Goor & Douwe J. Mulder. (2019) Rapid free thiol rebound is a physiological response following cold‐induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosis. Physiological Reports 7:6, pages e14017.
Crossref
Joanna Żuk, Agnieszka Snarska-Drygalska, Krzysztof Piotr Malinowski, Elżbieta Papuga-Szela, Joanna Natorska & Anetta Undas. (2019) Unfavourably altered plasma clot properties in patients with primary Raynaud’s phenomenon: association with venous thromboembolism. Journal of Thrombosis and Thrombolysis 47:2, pages 248-254.
Crossref
Soha Eldessouki Ibrahim, Caroline S. Morad, Naglaa Farouk & Amir Louis. (2018) Platelet indices as markers of inflammation in systemic sclerosis patients: Relation to vascular endothelial growth factor and flow mediated dilatation. The Egyptian Rheumatologist 40:4, pages 239-242.
Crossref
Zuzanna Małgorzata Łukasik, Marcin Makowski & Joanna Samanta Makowska. (2018) From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders. Rheumatology International 38:6, pages 959-974.
Crossref
Konstantinos Ntelis, Elena E. Solomou, Lazaros Sakkas, Stamatis-Nick Liossis & Dimitrios Daoussis. (2017) The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis. Seminars in Arthritis and Rheumatism 47:3, pages 409-417.
Crossref
Y. Mostmans, M. Cutolo, C. Giddelo, S. Decuman, K. Melsens, H. Declercq, E. Vandecasteele, F. De Keyser, O. Distler, J. Gutermuth & V. Smith. (2017) The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review. Autoimmunity Reviews 16:8, pages 774-786.
Crossref
Eric Boilard & Peter A. Nigrovic. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology 264 273.e3 .
Heather Gladue, Veronica Berrocal, Richard Harris, Pei-Suen Tsou, Gautam Edhayan, Ray Ohara & Dinesh Khanna. (2016) A randomized controlled trial of acupressure for the treatment of Raynaud's phenomenon: the difficulty of conducting a trial in Raynaud's phenomenon. Journal of Scleroderma and Related Disorders 1:2, pages 226-233.
Crossref
Daniela Hirigoyen, Paula I. Burgos, Veronica Mezzano, Josefina Duran, Magaly Barrientos, Claudia G. Saez, Olga Panes, Diego Mezzano & Mirentxu Iruretagoyena. (2015) Inhibition of angiogenesis by platelets in systemic sclerosis patients. Arthritis Research & Therapy 17:1.
Crossref
Laura Cappelli & Fredrick M. Wigley. (2015) Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. Rheumatic Disease Clinics of North America 41:3, pages 419-438.
Crossref
Michael W. Neumeister. (2015) The Role of Botulinum Toxin in Vasospastic Disorders of the Hand. Hand Clinics 31:1, pages 23-37.
Crossref
Marcella Prete, Maria Celeste Fatone, Elvira Favoino & Federico Perosa. (2014) Raynaud's phenomenon: From molecular pathogenesis to therapy. Autoimmunity Reviews 13:6, pages 655-667.
Crossref
Serdar Soydinc, Ibrahim Halil Turkbeyler, Yavuz Pehlivan, Gulcimen Soylu, Mehmet Fatih Goktepe, Muhammed Bilici, Orhan Zengin, Bunyamin Kisacik & Ahmet Mesut Onat. (2013) Mean Platelet Volume Seems To Be a Valuable Marker in Patients with Systemic Sclerosis. Inflammation 37:1, pages 100-106.
Crossref
Federico Díaz-González & Mark H. Ginsberg. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology 245 254 .
L. Polidoro, R. Barnabei, P. Giorgini, L. Petrazzi, C. Ferri & G. Properzi. (2012) Platelet activation in patients with the Raynaud phenomenon. Internal Medicine Journal 42:5, pages 531-535.
Crossref
ALBERTO SULLI, STEFANO SOLDANO, CARMEN PIZZORNI, PAOLA MONTAGNA, MARIA ELENA SECCHI, BARBARA VILLAGGIO, BRUNO SERIOLO, RENATA BRIZZOLARA & MAURIZIO CUTOLO. (2009) Raynaud’s Phenomenon and Plasma Endothelin: Correlations with Capillaroscopic Patterns in Systemic Sclerosis. The Journal of Rheumatology 36:6, pages 1235-1239.
Crossref
Fredrick M. Wigley. (2008) Vascular Disease in Scleroderma. Clinical Reviews in Allergy & Immunology 36:2-3, pages 150-175.
Crossref
James M. Edwards. 2009. Comprehensive Vascular and Endovascular Surgery. Comprehensive Vascular and Endovascular Surgery 309 317 .
S Fessatou, P Nicolaidou, D Gourgiotis, H Georgouli, K Douros, M Moustaki & A Fretzayas. (2008) Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatrics 8:1.
Crossref
Richard Bakst, Joseph F. Merola, Andrew G. FranksJr.Jr. & Miguel Sanchez. (2008) Raynaud's phenomenon: Pathogenesis and management. Journal of the American Academy of Dermatology 59:4, pages 633-653.
Crossref
Arnold E Postlethwaite & Thomas M Chiang. (2007) Platelet contributions to the pathogenesis of systemic sclerosis. Current Opinion in Rheumatology 19:6, pages 574-579.
Crossref
Gülsüm Emel Pamuk, Burhan Turgut, Ömer Nuri Pamuk, Özden Vural, Muzaffer Demir & Necati Çakr. (2007) Increased circulating platelet–leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study. Blood Coagulation & Fibrinolysis 18:4, pages 297-302.
Crossref
A. L. Herrick. (2005) Pathogenesis of Raynaud's phenomenon. Rheumatology 44:5, pages 587-596.
Crossref
Maureen D. Mayes. (2003) Endothelin and endothelin receptor antagonists in systemic rheumatic disease. Arthritis & Rheumatism 48:5, pages 1190-1199.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.